Tech Company Financing Transactions
Telephus Medical Funding Round
Telephus Medical, based in San Diego, secured $1.4 million from private investors and WS Investment.
Transaction Overview
Company Name
Announced On
12/5/2013
Transaction Type
Venture Equity
Amount
$1,400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12707 High Bluff Dr. 200
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Telephus is developing TPH 101, a first-in-class humanized monoclonal antibody to prevent Staphylococcus reinfection and accompanying osteomyelitis in patients receiving total hip arthroplasty (THA) or total knee arthroplasty (TKA) septic revision surgery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Benedyk
Chief Financial Officer
Steve Zaniboni
Chief Scientific Officer
Edward Schwarz
VP - Bus. Development
Michael Wood
VP - Finance
Lynne Rollins
VP - Manufacturing
Barry Rosenblatt
VP - Operations
Robert Geckeler
VP - Regulatory Affairs
Caryn Peterson
Browse more venture capital transactions:
Prev: 12/5/2013: Glassdoor venture capital transaction
Next: 12/6/2013: Network Medical venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document tech company VC transactions. All VC database entries on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs